Theranostics & Radioligand Strategies LLC. was founded by Andrew Beck, B.S., MBA, CNMT  in 2011.  A Radiopharmaceutical Industry Veteran of more than 30 years, Mr. Beck has held Executive and Senior Executive Leadership roles with Cardinal Health, Lantheus, Progenics Pharmaceuticals, Syncor International Corporation, and the Lehigh Valley Health Network.

 

Across the organization, we have generated billions of dollars in revenue by researching, preparing, launching, commercializing, and growing the adoption of a wide range of radiopharmaceutical diagnostics, radiopharmaceutical therapeutics, and theranostics.  We would welcome the opportunity to leverage our unique expertise to help you to fully realize the revenue growth and profitability of the assets in which you’ve invested.